CMG Pharmaceutical Co., Ltd. (058820.KQ)

KRW 1883.0

(-0.79%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 186.85 Billion 169.35 Billion 6.65 Billion 5.98 Billion 166.39 Billion 102.74 Billion
Total Current Assets 89.32 Billion 107.26 Billion 1.38 Billion 1.42 Billion 130.34 Billion 73.09 Billion
Cash And Short Term Investments 53.12 Billion 61.79 Billion 1.07 Billion 951.6 Million 103.49 Billion 48.92 Billion
Cash and Cash Equivalents 958.97 Million 3.53 Billion 815.37 Million 607.98 Million 16.07 Billion 12.09 Billion
Short Term Investments 52.16 Billion 58.25 Billion 260.94 Million 343.61 Million 33.75 Billion 36.82 Billion
Net Receivables 17.99 Billion 16.93 Billion 99.59 Million 104.5 Million 17.56 Billion 15.5 Billion
Inventory 15.87 Billion 16.89 Billion 32.82 Million 26.44 Million 7.83 Billion 7.7 Billion
Other Current Assets 2.21 Billion 11.52 Billion 172.82 Million 337.68 Million 1.38 Billion 924.62 Million
Total Non-Current Assets 97.52 Billion 62.09 Billion 5.27 Billion 4.56 Billion 36.05 Billion 29.65 Billion
Net PPE 39.13 Billion 29.75 Billion 4.88 Billion 4.35 Billion 20.87 Billion 15.51 Billion
Good Will And Intangible Assets 4.59 Billion 2.46 Billion 21.93 Million 21.93 Million 1.15 Billion 963.65 Million
Good Will 1.75 Billion - 21.93 Million 21.93 Million - -
Intangible Assets 2.83 Billion 2.46 Billion - - 1.15 Billion 963.65 Million
Long-Term Investments 40.56 Billion 18.26 Billion 283.56 Million 111.85 Million 3.46 Billion 4.18 Billion
Tax Assets 2.97 Billion - - - - -
Other Non Current Assets 10.25 Billion 11.6 Billion 78.32 Million 77.36 Million 10.55 Billion 8.99 Billion
Other Assets - - 1.00 1.00 - -
Total Liabilities 40.02 Billion 22.48 Billion 4.35 Billion 3.96 Billion 10.46 Billion 9.34 Billion
Total Current Liabilities 18.93 Billion 17.39 Billion 873.68 Million 822.19 Million 8.05 Billion 7.63 Billion
Account Payables 7.09 Billion 8.93 Billion 163.16 Million 121.99 Million 3.74 Billion 3.73 Billion
Tax Payables 364.19 Million 361.46 Million 724 Million 80.23 Million - -
Short Term Debt 679.18 Million - - - - -
Deferred Revenue 257.71 Million - - - - -
Other Current Liabilities 10.89 Billion 5.86 Billion 710.52 Million 700.2 Million 2.41 Billion 2.65 Billion
Total Non Current Liabilities 21.09 Billion 5.08 Billion 3.48 Billion 3.14 Billion 2.4 Billion 1.7 Billion
Long-Term Debt 19.06 Billion 4.76 Billion 3.3 Billion 2.95 Billion - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.03 Billion 38.42 Million 180.3 Million 188.26 Million 2.26 Billion 1.7 Billion
Other Liabilities - - - - - -
Total Equity 146.82 Billion 146.87 Billion 2.29 Billion 2.02 Billion 155.93 Billion 93.4 Billion
Stock Holders Equity 146.82 Billion 146.87 Billion 2.29 Billion 2.02 Billion 155.93 Billion 93.4 Billion
Common Stock 53.59 Billion 55.15 Billion 371 Thousand 367 Thousand 60.11 Billion 48.9 Billion
Retained Earnings 10.97 Billion 7.14 Billion 3.92 Billion 3.27 Billion 4.37 Billion 2.07 Billion
Accumulated other comprehensive income 1.48 Billion 1.48 Billion -5.35 Million -4.22 Million 731.6 Million 398.01 Million
Common Stock Equity 146.82 Billion 146.87 Billion 2.29 Billion 2.02 Billion 155.93 Billion 93.4 Billion
Capital Lease Obligation 538.22 Million 712.84 Million 510.06 Million 491.24 Million 247.89 Million -
Total Investments 92.73 Billion 76.51 Billion 544.5 Million 455.47 Million 37.22 Billion 41.01 Billion
Total Debt 19.74 Billion 4.76 Billion 3.3 Billion 2.95 Billion - -
Net Debt 18.78 Billion 1.22 Billion 2.48 Billion 2.34 Billion -16.07 Billion -12.09 Billion

Balance Sheet Charts